Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure.

By P. Armand, M. Shipp, V. Ribrag, J. Michot, P. Zinzani, J. Kuruvilla, Ellen Snyder, A. Ricart, A. Balakumaran, S. Rose and 1 more. Journal of Clinical Oncology, 2016

615 citations recorded by the source corpus.

Subfields: Immunology, Oncology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/1e88d94dec6f5b3898c366eae0c4d954040ccd84